ArticleAmerican journal of cancer research2016

Differences in MEK inhibitor efficacy in molecularly characterized low-grade serous ovarian cancer cell lines.

Marta Llauradó Fernández et al.PubMed ↗Full text ↗

No numbers read from the abstract.